SCHEDULE 13G

Amendment No. 2
Amedisys, Inc.
Common Stock
Cusip #023436108


Cusip #023436108
Item 1:	Reporting Person - FMR LLC
Item 4:	Delaware
Item 5:	1,472,144
Item 6:	0
Item 7:	4,354,144
Item 8:	0
Item 9:	4,354,144
Item 11:	15.000%
Item 12:	    HC


Cusip #023436108
Item 1:	Reporting Person - Edward C. Johnson 3d
Item 4:	United States of America
Item 5:	0
Item 6:	0
Item 7:	4,354,144
Item 8:	0
Item 9:	4,354,144
Item 11:	15.000%
Item 12:	IN




	SCHEDULE 13G - TO BE INCLUDED IN
STATEMENTS
	FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b)



Item 1(a).	Name of Issuer:

		Amedisys, Inc.

Item 1(b).	Name of Issuer's Principal Executive Offices:

		5959 S. Sherwood Forest Blvd
		Baton Rouge, LA  70816


Item 2(a).	Name of Person Filing:

		FMR LLC

Item 2(b).	Address or Principal Business Office or, if None,
Residence:

		82 Devonshire Street, Boston,
Massachusetts  02109

Item 2(c).	Citizenship:

		Not applicable

Item 2(d).	Title of Class of Securities:

		Common Stock

Item 2(e).	CUSIP Number:

		023436108

Item 3.	This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b)
and the person filing, FMR LLC, is a parent holding company
in accordance with Section 240.13d-1(b)(ii)(G).  (Note:  See
Item 7).

Item 4.	Ownership

	(a)	Amount Beneficially Owned:	4,354,144

	(b)	Percent of Class:	15.000%

	(c)	Number of shares as to which such
person has:

	(i)	sole power to vote or to direct
the vote:	1,472,144

	(ii)	shared power to vote or to
direct the vote:	0

	(iii)	sole power to dispose or to
direct the disposition of:	4,354,144

	(iv)	shared power to dispose or to
direct the disposition of:	0



Item 5.	Ownership of Five Percent or Less of a Class.

	Not applicable.

Item 6.	Ownership of More than Five Percent on Behalf of Another
Person.

	Various persons have the right to receive or the power to
direct the receipt of dividends from, or the proceeds from the
sale of, the Common Stock of Amedisys, Inc..  The interest of
one person, Fidelity Low-Priced Stock Fund, an investment
company registered under the Investment Company Act of
1940, in the Common Stock of Amedisys, Inc., amounted to
2,882,000 shares or 9.928% of the total outstanding Common
Stock at December 31, 2010. The interest of one person,
Fidelity Northstar Fund, an investment company registered
under the Investment Company Act of 1940, in the Common
Stock of Amedisys, Inc., amounted to 1,462,564 shares or
5.038% of the total outstanding Common Stock at December
31, 2010.

Item 7.	Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent
Holding Company.

	See attached Exhibit A.

Item 8.	Identification and Classification of Members of
the Group.

	Not applicable.  See attached Exhibit A.

Item 9.	Notice of Dissolution of Group.

	Not applicable.

Item 10.	Certification.

	By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the
purpose of and do not have the effect of changing or
influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in any
transaction having such purpose or effect.

Signature

	After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement
is true, complete and correct.

February 11, 2011
Date

 /s/ Scott C. Goebel
Signature

Scott C. Goebel
Duly authorized under Power of Attorney
effective as of June 1, 2008 by and on behalf of FMR LLC
and its direct and indirect  subsidiaries


	SCHEDULE 13G - TO BE INCLUDED IN
STATEMENTS
	FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b)



	Pursuant to the instructions in Item 7 of Schedule 13G,
Fidelity Management & Research Company ("Fidelity"), 82
Devonshire Street, Boston, Massachusetts 02109, a wholly-
owned subsidiary of FMR LLC and an investment adviser
registered under Section 203 of the Investment Advisers Act
of 1940, is the beneficial owner of 2,882,000 shares or 9.928%
of the Common Stock outstanding of Amedisys, Inc.  ("the
Company") as a result of acting as investment adviser to
various investment companies registered under Section 8 of
the Investment Company Act of 1940.

	The ownership of one investment company, Fidelity
Low-Priced Stock Fund, amounted to 2,882,000 shares or
9.928% of the Common Stock outstanding. Fidelity Low-
Priced Stock Fund has its principal business office at 82
Devonshire Street, Boston, Massachusetts 02109.

	The ownership of one investment company, Fidelity
Northstar Fund, amounted to 1,462,564 shares or 5.038% of
the Common Stock outstanding. Fidelity Northstar Fund has
its principal business office at 82 Devonshire Street, Boston,
Massachusetts 02109.

	Edward C. Johnson 3d and FMR LLC, through its
control of Fidelity, and the funds each has sole power to
dispose of the 2,882,000 shares owned by the Funds.

	Members of the family of Edward C. Johnson 3d,
Chairman of FMR LLC, are the predominant owners, directly
or through trusts, of Series B voting common shares of FMR
LLC, representing 49% of the voting power of FMR LLC.
The Johnson family group and all other Series B shareholders
have entered into a shareholders' voting agreement under
which all Series B voting common shares will be voted in
accordance with the majority vote of Series B voting common
shares.  Accordingly, through their ownership of voting
common shares and the execution of the shareholders' voting
agreement, members of the Johnson family may be deemed,
under the Investment Company Act of 1940, to form a
controlling group with respect to FMR LLC.

	Neither FMR LLC nor Edward C. Johnson 3d,
Chairman of FMR LLC, has the sole power to vote or direct
the voting of the shares owned directly by the Fidelity Funds,
which power resides with the Funds' Boards of Trustees.
Fidelity carries out the voting of the shares under written
guidelines established by the Funds' Boards of Trustees.

	Pyramis Global Advisors, LLC ("PGALLC"), 900
Salem Street, Smithfield, Rhode Island, 02917, an indirect
wholly-owned subsidiary of FMR LLC and an investment
adviser registered under Section 203 of the Investment
Advisers Act of 1940, is the beneficial owner of 1,462,564
shares or 5.038% of the outstanding Common Stock of
Amedisys, Inc. as a result of its serving as investment adviser
to institutional accounts, non-U.S. mutual funds, or investment
companies registered under Section 8 of the Investment
Company Act of 1940 owning such shares.

	Edward C. Johnson 3d and FMR LLC, through its
control of PGALLC, each has sole dispositive power over
1,462,564 shares and sole power to vote or to direct the voting
of 1,462,564 shares of Common Stock owned by the
institutional accounts or funds advised by PGALLC as
reported above.

	Pyramis Global Advisors Trust Company ("PGATC"),
900 Salem Street, Smithfield, Rhode Island, 02917, an indirect
wholly-owned subsidiary of FMR LLC and a bank as defined
in Section 3(a)(6) of the Securities Exchange Act of 1934, is
the beneficial owner of 9,580 shares or 0.033% of the
outstanding Common Stock of the Amedisys, Inc. as a result
of its serving as investment manager of institutional accounts
owning such shares.

	Edward C. Johnson 3d and FMR LLC, through its
control of Pyramis Global Advisors Trust Company, each has
sole dispositive power over 9,580 shares and sole power to
vote or to direct the voting of 9,580 shares of Common Stock
owned by the institutional accounts managed by PGATC as
reported above.



	SCHEDULE 13G - TO BE INCLUDED IN
STATEMENTS
	FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b)
	RULE 13d-1(f)(1)  AGREEMENT

	The undersigned persons, on February 11, 2011, agree
and consent to the joint filing on their behalf of this Schedule
13G in connection with their beneficial ownership of the
Common Stock of Amedisys, Inc. at December 31, 2010.

	FMR LLC

	By /s/ Scott C. Goebel
	Scott C. Goebel
	Duly authorized under Power of Attorney effective as
of June 1, 2008, by and on behalf of FMR LLC and its direct
and indirect subsidiaries

	Edward C. Johnson 3d

	By /s/ Scott C. Goebel
	Scott C. Goebel
	Duly authorized under Power of Attorney effective as
of June 1, 2008, by and on behalf of Edward C. Johnson 3d

	Fidelity Management & Research Company

	By /s/ Scott C. Goebel
	Scott C. Goebel
	Senior V.P. and General Counsel

	Fidelity Low-Priced Stock Fund

	By /s/ Scott C. Goebel
	Scott C. Goebel
	Secretary

	Fidelity Northstar Fund

	By /s/ Scott C. Goebel
	Scott C. Goebel
	Secretary

	Pyramis Global Advisors, LLC

	By /s/ Ashling Kanavos
	Ashling Kanavos
	Duly authorized under Power of Attorney
	dated April 6, 2009, by William E. Dailey
	Chief Financial Officer and Treasurer